BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Authors » John Brosky

Articles by John Brosky

EU Parliament votes into law regulations for IVDs, med devices

April 6, 2017
By John Brosky
PARIS – It's almost official. After eight years of hard-fought negotiating, the European Parliament repealed the 30-page Medical Device Directives governing the Conformité Européen certification, or CE Mark, and adopted the 600 pages of the Medical Device Regulation (MDR) and In vitro Diagnostic Medical Devices (IVDR).
Read More

Lisbon start up ready to leap from Europe footprint to world stage

April 4, 2017
By John Brosky

Philips launches next-generation intervention platform integrating acquired Volcano products

March 14, 2017
By John Brosky

Pocket ultrasound accelerates trend for fast diagnosis away from radiologists

March 9, 2017
By John Brosky

Hyperpolarized MRI surpasses PET-CT revealing human biology in vivo

March 6, 2017
By John Brosky

Radiologists turn to AI for migrating diagnostic reports into digital age

March 3, 2017
By John Brosky

Artificial intelligence seen moving rapidly into data-rich radiology domains, says Dryer

March 2, 2017
By John Brosky

EU finalizes more stringent CE mark rules with explosive 'supernova' of regulation

Feb. 27, 2017
By John Brosky
PARIS – The CE mark is dead, long live the new CE mark. Five years after launching a reform of regulations for commercializing medical devices and in vitro diagnostics (IVDs), the European Council released the final text for the Medical Device Regulations (MDR) and IVD Regulations (IVDR), setting in motion a countdown to enforcement. "The future is in this version and like it or not, this is what we will work with, what we need to make a success, because the alternative that it does not work is so much worse," said Ronald Boumans, the...
Read More

EU finalizes more stringent CE mark rules with explosive 'supernova' of regulation

Feb. 27, 2017
By John Brosky
PARIS – The CE mark is dead, long live the new CE mark. Five years after launching a reform of regulations for commercializing medical devices and in vitro diagnostics (IVDs), the European Council released the final text for the Medical Device Regulations (MDR) and IVD Regulations (IVDR), setting in motion a countdown to enforcement.
Read More

Trod Medical's Encage spiral probe zaps tumors but leaves a functional prostate

Feb. 24, 2017
By John Brosky
Previous 1 2 3 4 5 6 7 8 9 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing